Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
SYNACT PHARMA ApS
APS
Active
Advertising protection
CVR 34459975
Dronninggårds Alle 136, 2840
Holte
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2012 · 14 years old
7 employees
Monitor
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
SYNACT PHARMA ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Related companies
Company hierarchy
SynAct Pharma AB
100%
TJ BIOTECH HOLDING ApS
33.33%
Forsknings-, Uddannelses- og Digitaliseringsministeriet
25%
NORDIC BIOTECH HOLDING ApS
5%
QUANTASS ApS
25%
GL Capital AB
10%
Next Stage Ventures ApS
5%
SYNACT PHARMA ApS
(this company)
Board network connections
Board members of SYNACT PHARMA ApS also hold positions in
30
other companies.
Person
Role here
Other companies
Jeppe Øvli Øvlesen
Chief Executive Officer
11 companies
Many roles
Henrik Stage
Management
6 companies
Many roles
Thomas Boesen
Management
4 companies
Thomas Engelbrecht Nordkild Jonassen
Board of Directors
4 companies
Bruno Sten Rosenkrans Jensen
Audit
2 companies
Sigbjørn Georg Nielsen Kjærgård
Chief Executive Officer
2 companies
Ann Kristin Brøgger Led
Management
1 company
More on SYNACT PHARMA ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
People & ownership →
Management, board and shareholder breakdown
SynAct Pharma AB
SYNACT PHARMA ApS